Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Pharmaceutical Design
  4. Volume 30, Issue 36
  5. Article
Volume 30, Issue 36
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Background

Diabetic cardiomyopathy (DCM) is a common diabetes complication with limited medications. Gegen Qinlian decoction (GQD) has been used in the treatment of diabetes and its related complications in China for several decades.

Objective

In this study, network pharmacology was employed to predict the active ingredients, key targets, and pathways involved in the treatment of DCM by GQD and to validate it by animal experiments.

Methods

The active ingredients of GQD were retrieved from TCMSP and published literature. DCM-related gene targets were searched in Drugbank, Genecards, Disgenet, and OMIM disease databases. Protein-protein interaction networks were constructed using the STRING database and Cytoscape. GO analysis and KEGG pathway enrichment analysis were performed using the Metascape platform. Moreover, a diabetic mouse model was established to evaluate the therapeutic effects of GQD by measuring serum biochemical markers and inflammation levels. Finally, the expression of predicted key target genes was determined using real-time quantitative PCR.

Results

A total of 129 active ingredients were screened from GQD. Moreover, 146 intersecting genes related to DCM were obtained, with key targets, including AKT1, TNF, IL6, and VEGFA. Lipid and atherosclerosis, AGE-RAGE, PI3K-AKT, and MAPK pathways were identified. Blood glucose control, decreased inflammatory factors, and serum CK-MB levels were restored after GQD intervention, and the same occurred with the expressions of PPAR-γ, AKT1, APOB, and GSK3B genes.

Conclusion

Quercetin, kaempferol, wogonin, 7-methoxy-2-methyl isoflavone, and formononetin may exert major therapeutic effects by regulating key factors, such as AKT1, APOB, and GSK3B, in the inflammatory reaction, glycolipid oxidation, and glycogen synthesis related signaling pathways.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cpd/10.2174/0113816128312242240722080551
2024-08-12
2024-12-25

  • From This Site

    /content/journals/cpd/10.2174/0113816128312242240722080551
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. ReuschJ.E.B. MansonJ.E. Management of type 2 diabetes in 2017.JAMA2017317101015101610.1001/jama.2017.0241 28249081
     [Google Scholar]
  2. SaeediP. PetersohnI. SalpeaP. MalandaB. KarurangaS. UnwinN. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.Diabetes Res Clin Pr201915710784310.1016/j.diabres.2019.107843
     [Google Scholar]
  3. MendisS. DavisS. NorrvingB. Organizational update.Stroke2015465e121e12210.1161/STROKEAHA.115.008097 25873596
     [Google Scholar]
  4. JiaG. HillM.A. SowersJ.R. Diabetic cardiomyopathy.Circ. Res.2018122462463810.1161/CIRCRESAHA.117.311586 29449364
     [Google Scholar]
  5. SurguchovA. BernalL. SurguchevA.A. Phytochemicals as regulators of genes involved in synucleinopathies.Biomolecules202111562410.3390/biom11050624 33922207
     [Google Scholar]
  6. YaoY. WangD.F. XiangF. LuoY.P. Research progress of traditional Chinese medicine in the treatment of diabetes complicated with osteoporosis.MEDS Chinese Med20224481410.23977/medcm.2022.040402
     [Google Scholar]
  7. XuY. HuangJ. WangN. Network pharmacology-based analysis and experimental exploration of antidiabetic mechanisms of Gegen Qinlian decoction.Front. Pharmacol.20211264960610.3389/fphar.2021.649606 34381354
     [Google Scholar]
  8. TongX. ZhaoL. LianF. Clinical observations on the dose-effect relationship of Gegen Qin Lian decoction on 54 out-patients with type 2 diabetes.J. Tradit. Chin. Med.2011311565910.1016/S0254‑6272(11)60013‑7 21563509
     [Google Scholar]
  9. HeL. BaoT. YangY. Exploring the pathogenesis of type 2 diabetes mellitus intestinal damp-heat syndrome and the therapeutic effect of Gegen Qinlian decoction from the perspective of exosomal miRNA.J. Ethnopharmacol.202228511478610.1016/j.jep.2021.114786 34763043
     [Google Scholar]
  10. XiongX.J. Gegen Qinlian decoction formula syndrome and its application in diabetes, hypertension, hyperlipidemia and obesity.Zhongguo Zhongyao Zazhi202045122760276410.19540/j.cnki.cjcmm.20190829.501 32627448
     [Google Scholar]
  11. Chinese Pharmacopoeia Commission.In: Pharmacopoeia of the People’s Republic of China.Beijing, ChinaPeople’s Medical Publishing2015
     [Google Scholar]
  12. BoudinaS. AbelE.D. Diabetic cardiomyopathy revisited.Circulation2007115253213322310.1161/CIRCULATIONAHA.106.679597 17592090
     [Google Scholar]
  13. TanY. ZhangZ. ZhengC. WintergerstK.A. KellerB.B. CaiL. Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: Preclinical and clinical evidence.Nat. Rev. Cardiol.202017958560710.1038/s41569‑020‑0339‑2 32080423
     [Google Scholar]
  14. XiaW. LiX. WuQ. XuA. ZhangL. XiaZ. The importance of caveolin as a target in the prevention and treatment of diabetic cardiomyopathy.Front. Immunol.20221395138110.3389/fimmu.2022.951381 36405687
     [Google Scholar]
  15. XuX. NiuL. LiuY. Study on the mechanism of Gegen Qinlian decoction for treating type II diabetes mellitus by integrating network pharmacology and pharmacological evaluation.J. Ethnopharmacol.202026211312910.1016/j.jep.2020.113129 32730886
     [Google Scholar]
  16. LiuW. XiongX. FengB. YuanR. ChuF. LiuH. Classic herbal formula Zhigancao decoction for the treatment of premature ventricular contractions (PVCs): A systematic review of randomized controlled trials.Complement. Ther. Med.201523110011510.1016/j.ctim.2014.12.008 25637158
     [Google Scholar]
  17. WangN. ZhangJ. XuH. WangG. ChuL. Effects of Buzhong Yiqi decoction on adriamycin induced heart failure in rats.Zhongguo Zhongyao Zazhi201136450851010.4268/cjcmm20110430 21598554
     [Google Scholar]
  18. ZhenZ. ChangB. LiM. Anti-diabetic effects of a Coptis chinensis containing new traditional Chinese medicine formula in type 2 diabetic rats.Am. J. Chin. Med.2011391536310.1142/S0192415X11008646 21213398
     [Google Scholar]
  19. Moosavi-MovahediA.A. HakimelahiS. ChamaniJ. Design, synthesis, and anticancer activity of phosphonic acid diphosphate derivative of adenine-containing butenolide and its water-soluble derivatives of paclitaxel with high antitumor activity.Bioorg. Med. Chem.200311204303431310.1016/S0968‑0896(03)00524‑8 13129566
     [Google Scholar]
  20. KalhoriF. YazdyaniH. KhademorezaeianF. Enzyme activity inhibition properties of new cellulose nanocrystals from Citrus medica L. pericarp: A perspective of cholesterol lowering.Luminescence202237111836184510.1002/bio.4360 35946171
     [Google Scholar]
  21. Malek-EsfandiariZ. Rezvani-NoghaniA. SohrabiT. MokaberiP. Amiri-TehranizadehZ. ChamaniJ. Molecular dynamics and multi-spectroscopic of the interaction behavior between bladder cancer cells and calf thymus DNA with rebeccamycin: Apoptosis through the down regulation of PI3K/AKT signaling pathway.J. Fluoresc.20233341537155710.1007/s10895‑023‑03169‑4 36787038
     [Google Scholar]
  22. KabiriM. Amiri-TehranizadehZ. BaratianA. SaberiM.R. ChamaniJ. Use of spectroscopic, zeta potential and molecular dynamic techniques to study the interaction between human holo-transferrin and two antagonist drugs: Comparison of binary and ternary systems.Molecules20121733114314710.3390/molecules17033114 22410420
     [Google Scholar]
  23. HamidM FatemehH NiloofarS ElaheK BizhanMN ParisaM Glucokinase activity enhancement by cellulose nanocrystals isolated from jujube seed: A novel perspective for type II diabetes mellitus treatment (In vitro).J Mol Struct202212692022133803
     [Google Scholar]
  24. SolinasG. VilcuC. NeelsJ.G. JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity.Cell Metab.20076538639710.1016/j.cmet.2007.09.011 17983584
     [Google Scholar]
  25. KhalidM. AlkaabiJ. KhanM.A.B. AdemA. Insulin signal transduction perturbations in insulin resistance.Int. J. Mol. Sci.20212216859010.3390/ijms22168590 34445300
     [Google Scholar]
  26. ChavaliV. TyagiS.C. MishraP.K. Differential expression of dicer, miRNAs, and inflammatory markers in diabetic Ins2+/- Akita hearts.Cell Biochem. Biophys.2014681253510.1007/s12013‑013‑9679‑4 23797610
     [Google Scholar]
  27. Gonzalez RodriguezA. SchroederM.E. GrimJ.C. Tumor necrosis factor-α promotes and exacerbates calcification in heart valve myofibroblast populations.FASEB J.2021353e2138210.1096/fj.202002013RR 33554387
     [Google Scholar]
  28. FangG. LiY. YuanJ. Cadherin-11-interleukin-6 signaling between cardiac fibroblast and cardiomyocyte promotes ventricular remodeling in a mouse pressure overload-induced heart failure model.Int. J. Mol. Sci.2023247654910.3390/ijms24076549 37047522
     [Google Scholar]
  29. ZhangY. WangJ.H. ZhangY.Y. Deletion of interleukin-6 alleviated interstitial fibrosis in streptozotocin-induced diabetic cardiomyopathy of mice through affecting TGFβ1 and miR-29 pathways.Sci. Rep.2016612301010.1038/srep23010 26972749
     [Google Scholar]
  30. WeiC. LiL. KimI.K. SunP. GuptaS. NF-κB mediated miR-21 regulation in cardiomyocytes apoptosis under oxidative stress.Free Radic. Res.201448328229110.3109/10715762.2013.865839 24237305
     [Google Scholar]
  31. WangY. JiangC. ShangZ. AGEs/RAGE promote osteogenic differentiation in rat bone marrow-derived endothelial progenitor cells via MAPK signaling.J. Diabetes Res.2022202211110.1155/2022/4067812 35155684
     [Google Scholar]
  32. MishraR.K. Potential role of nuclear factor κB in cardiovascular disease.In: Emerging applications, perspectives, and discoveries in cardiovascular research.IGI Global201710.4018/978‑1‑5225‑2092‑4.ch003
     [Google Scholar]
  33. LiF. ChenL. ZhengJ. Mechanism of Gegen Qinlian decoction regulating ABTB1 expression in colorectal cancer metastasis based on PI3K/AKT/FOXO1 pathway.BioMed Res. Int.202220221710.1155/2022/8131531 35111848
     [Google Scholar]
  34. ManningB.D. TokerA. AKT/PKB signaling: Navigating the network.Cell2017169338140510.1016/j.cell.2017.04.001 28431241
     [Google Scholar]
  35. YanaiH. YoshidaH. Beneficial effects of adiponectin on glucose and lipid metabolism and atherosclerotic progression: Mechanisms and perspectives.Int. J. Mol. Sci.2019205119010.3390/ijms20051190 30857216
     [Google Scholar]
  36. JingX. ZhouJ. ZhangN. A review of the effects of puerarin on glucose and lipid metabolism in metabolic syndrome: Mechanisms and opportunities.Foods20221123394110.3390/foods11233941 36496749
     [Google Scholar]
  37. BeurelE. GriecoS.F. JopeR.S. Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases.Pharmacol. Ther.201514811413110.1016/j.pharmthera.2014.11.016 25435019
     [Google Scholar]
  38. FernandezA.M. Torres-AlemánI. The many faces of insulin-like peptide signalling in the brain.Nat. Rev. Neurosci.201213422523910.1038/nrn3209 22430016
     [Google Scholar]
  39. SaraswatiA.P. Ali HussainiS.M. KrishnaN.H. BabuB.N. KamalA. Glycogen synthase kinase-3 and its inhibitors: Potential target for various therapeutic conditions.Eur. J. Med. Chem.201814484385810.1016/j.ejmech.2017.11.103 29306837
     [Google Scholar]
  40. IkebukuroK. AdachiY. YamadaY. Treatment of streptozotocin-induced diabetes mellitus by transplantation of islet cells plus bone marrow cells via portal vein in rats1.Transplantation200273451251810.1097/00007890‑200202270‑00004 11889421
     [Google Scholar]
  41. XuM. WangX. LiY. Arachidonic acid metabolism controls macrophage alternative activation through regulating oxidative phosphorylation in PPARγ dependent manner.Front. Immunol.20211261850110.3389/fimmu.2021.618501 34149684
     [Google Scholar]
  42. OikonomouE. MourouzisK. FountoulakisP. Interrelationship between diabetes mellitus and heart failure: The role of peroxisome proliferator-activated receptors in left ventricle performance.Heart Fail. Rev.201823338940810.1007/s10741‑018‑9682‑3 29453696
     [Google Scholar]
  43. KongthitilerdP. SuantaweeT. ChengH. ThilavechT. MarnpaeM. AdisakwattanaS. Anthocyanin-enriched riceberry rice extract inhibits cell proliferation and adipogenesis in 3T3-L1 preadipocytes by downregulating adipogenic transcription factors and their targeting genes.Nutrients2020128248010.3390/nu12082480 32824545
     [Google Scholar]
  44. MutluA.S. DuffyJ. WangM.C. Lipid metabolism and lipid signals in aging and longevity.Dev. Cell202156101394140710.1016/j.devcel.2021.03.034 33891896
     [Google Scholar]
/content/journals/cpd/10.2174/0113816128312242240722080551
Loading
Active Ingredients and Mechanism of Gegen Qinlian Decoction in the Treatment of Diabetic Cardiomyopathy: A Network Pharmacology Study
Curr. Pharm. Des. 30, 2896 (2024); https://doi.org/10.2174/0113816128312242240722080551
/content/journals/cpd/10.2174/0113816128312242240722080551
/content/journals/cpd/10.2174/0113816128312242240722080551
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): diabetic cardiomyopathy; experimental validation; Gegen Qinlian decoction; glycolipid metabolism; network pharmacology; protein-protein interaction

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test